Platelet-to-Lymphocyte Ratio as a Predictor of Atrial Fibrillation in STEMI Patients

12 June 2025 : Clinical Research

Tingting Li^{BCDEF 1}, Qi Zhang^{BCDEF 2}, Xiaosong Gu^{BE 3}, Yifei Tao^{AEF 4*}, Jiayu Yin^{ABCDEF 3}

DOI: 10.12659/MSM.948334

Med Sci Monit 2025; 31:e948334

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions Data Availability Statement References

Related articles Order reprints Share article Share by email

View HTML version

Table 5 ROC analysis of NOAF during hospitalization.

	AUC	95 CI%	P	CUT-OFF	Sensitivity	Specificity
LVEF, %	0.746	0.680~0.813	<0.001	49.5	0.623	0.777
PLR	0.653	0.576~0.730	<0.001	212.11	0.509	0.765
NT-proBNP, pg/mL	0.697	0.636~0.758	<0.001	1249.5	0.849	0.509
NT-proBNP+LVEF+PLR	0.778	0.717~0.840	<0.001	–	0.698	0.752
NOAF – new-onset atrial fibrillation; LVEF – left ventricular ejection fraction; NT-proBNP – N-terminal pro-B-type natriuretic peptide; NOAF – new-onset atrial fibrillation; PLR – platelet-to-lymphocyte ratio.

Back to the Article